Josh Sandberg


Mr. Sandberg has been an Entrepreneur in the area of medical technology for over 20 years. He has primarily focused in the areas of Spine, Orthopedics and Biologics in a variety of capacities. Mr. Sandberg played pivotal roles in early to mid-cap companies including two successful exits: Emerging Implant Technologies (President, US) and Axolotl Biologix (CEO). Due to some early opportunities, Mr. Sandberg was able to have a very broad view of organizational design and commercialization with specialty areas including: Corporate Governance, Building Highly Effective Teams, Commercialization, Market Access and Mergers & Acquisitions. Mr. Sandberg has been a co-founder of 4 other companies in the industry and serves as a Member of the Board of Directors for the following organizations: Surgio Health, OrthoEx, Global Spine Outreach, Axolotl Biologix as well as serving on the commercial advisory board for Moximed.